Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 296 entries
View as:

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01662908 Org: User:
Start: 08/31/12 End: 03/31/14 Due: 03/31/15

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01973569 Org: User:
Start: 10/31/13 End: 09/19/17 Due: 09/19/18

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

Phase: N/A Priority: Normal
NCT ID: NCT02345057 Org: User:
Start: 01/31/15 End: 07/31/16 Due: 07/31/17

Treatment of Pain Associated With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT02146430 Org: User:
Start: 10/27/14 End: 07/14/16 Due: 07/14/17

Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)

Phase: N/A Priority: Normal
NCT ID: NCT02952599 Org: User:
Start: 03/27/17 End: 10/29/19 Due: 10/29/20

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00017511 Org: User:
Start: 06/30/01 End: 03/31/03 Due: 03/31/04

A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate

Phase: N/A Priority: Normal
NCT ID: NCT06772246 Org: User:
Start: 10/24/24 End: 10/09/25 Due: 10/09/26

Multiple Dose Study of D1971a in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02564861 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00064220 Org: User:
Start: 04/30/03 End: 12/31/05 Due: 12/31/06

Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02258880 Org: User:
Start: 09/30/14 End: 05/31/16 Due: 05/31/17

CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin

Phase: N/A Priority: Normal
NCT ID: NCT00969033 Org: User:
Start: 07/31/09 End: 12/31/11 Due: 12/31/12

Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib

Phase: N/A Priority: Normal
NCT ID: NCT03746912 Org: User:
Start: - End: - Due: -

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03523572 Org: User:
Start: 08/02/18 End: 09/12/23 Due: 09/12/24

The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00185055 Org: User:
Start: 11/30/04 End: 02/28/05 Due: 02/28/06

DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix

Phase: N/A Priority: Normal
NCT ID: NCT00004866 Org: User:
Start: 01/31/00 End: 09/30/03 Due: 09/30/04

A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02448628 Org: User:
Start: 05/31/15 End: 12/31/15 Due: 12/31/16

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Phase: N/A Priority: Normal
NCT ID: NCT03734029 Org: User:
Start: 12/27/18 End: 10/01/25 Due: 10/01/26

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT03305471 Org: User:
Start: 08/17/17 End: 01/03/19 Due: 01/03/20

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00527514 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Phase: N/A Priority: Normal
NCT ID: NCT00462761 Org: User:
Start: 01/31/07 End: 12/31/09 Due: 12/31/10

Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00649389 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT04276415 Org: User:
Start: 05/08/20 End: 03/11/22 Due: 03/11/23

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00857285 Org: User:
Start: 05/31/02 End: 09/30/03 Due: 09/30/04

Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT01512199 Org: User:
Start: 11/30/11 End: 01/28/15 Due: 01/28/16

Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040b

Phase: N/A Priority: Normal
NCT ID: NCT02647307 Org: User:
Start: 02/29/16 End: 06/30/16 Due: 06/30/17